“Establishing a Risk Model for Diabetic Nephropathy and Addressing the Therapeutic Effect of Combined Epalrestat- Dapagliflozin Regimen”.
Iranian Journal of Kidney Diseases 18, no. 05 (October 18, 2024). Accessed July 15, 2025.
https://ijkd.org/index.php/ijkd/article/view/8188.